Ikarian Capital’s Otonomy, Inc. OTIC Stock Holding History

Ikarian Capital’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-300,000	Closed	-$1.09M	–	227
2020 Q2	$1.09M	Hold	300,000	–	–	0.09%	121
2020 Q1	$591K	Buy	+300,000	New	+$925K	0.04%	130

Other funds holding OTIC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Ikarian Capital's OTIC Position: Q3 2022 in Review

Ikarian Capital sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 180 shares.

Ikarian Capital first reported a position in OTIC in Q4 2019 and held it in 10 quarters. The position peaked at $4.09M in Q4 2019. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

Ikarian Capital reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
Ikarian Capital sold 180 Otonomy, Inc. shares in Q3 2022.
Ikarian Capital first reported a position in Otonomy, Inc. in Q4 2019 and held it in 10 quarters.
Ikarian Capital's Otonomy, Inc. position peaked at $4.09M in Q4 2019.
40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.